AI assistant
Sending…
LifeMD, Inc. — Director's Dealing 2022
Feb 15, 2022
33298_dirs_2022-02-14_ee6402b5-4c5c-4883-8d09-ff3f19ab0a26.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: LifeMD, Inc. (LFMD)
CIK: 0000948320
Period of Report: 2021-12-31
Reporting Person: Schreiber Justin (CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-10-20 | Common Stock | G | 25000 | — | Disposed | 2854620 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-09-15 | Warrants to Purchase Common Stock | $1.75 | G | 96349 | Disposed | Common Stock (96349) | Direct |
Footnotes
F1: The warrant was exercisable in full as of January 12, 2019 and expired on January 12, 2022.
More from LifeMD, Inc.
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Jan 6
Director's Dealing
2025
Dec 11
Regulatory Filings
2025
Nov 24
Interim / Quarterly Report
2025
Nov 17
Regulatory Filings
2025
Nov 17